ICY-AKC-301 (TRAK) - Clinical Trial
¿Cuál es el Propósito de este estudio?
Study visits at week 0, 4, 6, 8, and 12.
¿Cuál es la Condición que se está estudiando?
Atopic keratoconjunctivitis (AKC) which is an allergic condition that causes red, itchy, watery eyes
¿Quién puede participar en el Estudio?
Participants with active AKC with symptoms of itching and eye redness
Grupo etario
Adultos
¿Qué Implica?
This study is testing an eye drop treatment to see if it is safe and works better than inactive eye drops. Participants will use one drop in each eye four times a day for 12 weeks. Researchers will compare the results between the study treatment and the inactive eye drops.
Detalles del Estudio
Título Completo
A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants with Atopic Keratoconjunctivitis (AKC) - TRAK
Investigador Principal
Amol A. Sura, MD
Especialista en oftalmología
Número de Protocolo
IRB:
PRO00119397
NCT:
NCT07395232
Fase
Phase III
ClinicalTrials.gov
Ver en ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción